Prescient Healthcare names new directors
17 May 2023 -

Prescient Healthcare Group, a biopharma product and portfolio strategy company, announced on Tuesday that it has named Dr Erica Carlisle, Dr Paul Harney and Swati Anand Kkatyal as its new directors.

Dr Carlisle serves as the head of Global Commercial Practice at the company. She has 20 years of experience in healthcare consulting and biotechnology, which includes eight years at the Boston Consulting Group, where she served as the North America topic leader for launch in biopharma. She has worked as vice president at Zymergen.

Dr Harney serves as the chief commercial officer at the company. He has spent over 25 years guiding and supporting the healthcare industry. He has served in leadership roles at various consulting companies, such as Deloitte and Quintiles.

Kkatyal serves as the head of our Global Data, Analytics and Technology Practice at the company. She has extensive experience consulting biopharma companies on new and mature brand planning strategies. She joined the company in 2008 and is based in its New Delhi office.